All In Biotech

Free tool

FAERS Monitor: Lonsurf

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207981 or its brand name (Lonsurf, Tipiracil Hydrochloride, Trifluridine). Reports on generic versions are filed under their own applications.

Reports

10,823

Serious

8,549

79% of reports

Hospitalization

2,990

Death reported

4,240

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death3,101
  • disease progression1,795
  • fatigue1,435
  • nausea1,202
  • diarrhoea1,040
  • decreased appetite695
  • vomiting649
  • asthenia510
  • white blood cell count decreased500
  • anaemia375
  • drug ineffective370
  • neutropenia362
  • constipation349
  • weight decreased339
  • dehydration334

Reports by year received

View as table
YearReports
201557
20161,355
20171,424
20181,345
2019944
2020964
2021971
2022870
20231,042
2024752
2025639
2026460

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,336 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
disease progressionSignal1,79529.928.749,666
white blood cell count decreasedSignal5009.08.33,550
deathSignal3,1017.06.816,616
decreased appetiteSignal6955.85.42,798
neutropeniaSignal3625.24.71,223
dehydrationSignal3344.94.41,029
anaemiaSignal3753.83.5786
fatigueSignal1,4353.63.42,772
diarrhoeaSignal1,0403.13.01,555
constipationSignal3493.12.8503
nauseaSignal1,2023.02.81,610
vomitingSignal6492.72.5699
astheniaSignal5102.62.4526
weight decreasedSignal3392.42.1268
drug ineffective3700.50.5149

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.